Uncategorized
Leiter’s Compounding Pharmacy recalls bevacizumab lots
Leiter’s Compounding Pharmacy has voluntarily issued a nationwide recall of three lots of sterile products due to concerns regarding its independent testing lab, Front Range Laboratories, according to a release from the U.S. Food and Drug Administration.The lots being recalled are bevacizumab Lot No. 08052013@1, expiry 11/03/13; bevacizumab Lot No. 08052013@4, expiry 11/03/13; and lidocaine/phenylephrine Lot No. 07302013@6, expiry 10/28/13.